Comparative levels of markers of plasminogen oxidative damage and glycation between control and diabetic samples at baseline
| Analyte . | Healthy controls (n = 12) . | Subjects with T1DM (baseline, n = 9) . | P . |
|---|---|---|---|
| FLPlasminogen, mol% | 1.82 ± 0.95 | 6.26 ± 3.43 | <.01 |
| MG-H1Plasminogen, mol% | 0.37 ± 0.12 | 0.52 ± 0.40 | >.1 |
| CMLPlasminogen, mol% | 0.58 ± 0.27 | 0.49 ± 0.14 | >.1 |
| Methionine sulfoxidePlasminogen, mol% | 6.37 ± 2.79 | 8.17 ± 4.64 | >.1 |
| Analyte . | Healthy controls (n = 12) . | Subjects with T1DM (baseline, n = 9) . | P . |
|---|---|---|---|
| FLPlasminogen, mol% | 1.82 ± 0.95 | 6.26 ± 3.43 | <.01 |
| MG-H1Plasminogen, mol% | 0.37 ± 0.12 | 0.52 ± 0.40 | >.1 |
| CMLPlasminogen, mol% | 0.58 ± 0.27 | 0.49 ± 0.14 | >.1 |
| Methionine sulfoxidePlasminogen, mol% | 6.37 ± 2.79 | 8.17 ± 4.64 | >.1 |